Data as of Mar 14
| +0.63 / +4.06%|
The 2 analysts offering 12-month price forecasts for Galectin Therapeutics Inc have a median target of 26.00, with a high estimate of 32.00 and a low estimate of 20.00. The median estimate represents a +61.09% increase from the last price of 16.14.
The current consensus among 2 polled investment analysts is to Buy stock in Galectin Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.